Increased telomerase activity, as can occur with TERT promoter mutations, can maintain telomere length and induce cell immortality, which may mechanistically explain the generally more aggressive clinicopathologic features associated with TERT promoter mutated thyroid carcinomas (22, 23). The gene discussed is TERT; the disease is thyroid gland carcinoma.